Pharmaceutical Executive to Unveil Brand of the Year Award Recipients at iPharma 2014: CBI's Marketing Innovation Summit

   Pharmaceutical Executive to Unveil Brand of the Year Award Recipients at
               iPharma 2014: CBI's Marketing Innovation Summit

PR Newswire

BOSTON, March 26, 2014

BOSTON, March 26, 2014 /PRNewswire/ -- CBI is pleased to announce that
Pharmaceutical Executive will reveal its prestigious Brand of the Year Award
during iPharma 2014 – industry's leading marketing innovation summit – taking
place May 8-9, 2014 in New York, NY. iPharma 2014 is the most compelling and
comprehensive life sciences meeting, uniting key stakeholders in the world of
digital marketing, strategy, branding, innovation, media, and IT to share the
latest trends and real-world approaches to developing effective and innovative
promotional campaigns. Executives from Arbor Pharmaceuticals, Auxilium, Bayer,
Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, CSL Behring,
EMD Serono, GE Healthcare, Inspirion, Lilly, Lundbeck, Merck, Novartis, Ova
Science, Pfizer, Purdue, Roche, Shire, UCB, Voltarra Pharmaceuticals and many
other leading organizations round out the highly anticipated agenda.

Pharmaceutical Executive's annual Brand of the Year selection, to be announced
during a special award ceremony at the conference, reflects the difficult
decisions made by scientific and commercial teams, spanning the entire
organization. In addition to the performance of the brand at launch and
successful quarterly figures, the cumulative decisions made that power a
brand's long-term trajectory – across multiple divisions, managers and
geographic areas – such as access issues, lifecycle management and meaningful
customer engagement will be key considerations.

Brand of the Year has been an annual feature in Pharmaceutical Executive
magazine since 2008, when Pfizer's Chantix, a smoking cessation drug, won the
inaugural designation. Since then, some of the largest brands on the market
have been selected and profiled, including Genentech's Avastin (2010) and
AbbVie's Humira (2012).

This year, a second Brand of the Year Award will be added for a rare disease
medicine, in response to industry's increasing interest in this critical area
of unmet need. Both Brand of the Year selections will be judged against the
competition in the market, performance to date and the brand team's ability to
engage successfully with patients, physicians, payers and regulators to affect
the entire ecosystem of care, from drug delivery to health outcomes.

For more information or to download the complete conference agenda, visit

About CBI:
CBI, an Advanstar company, is the leading provider of market-driven, unbiased
conferences for the pharmaceutical, biotechnology, medical device and
healthcare industries. CBI offers specialized information presented in
interactive formats by thought-leaders and regulators. For more information,
please visit or contact Emily Forest, Senior Marketing Manager,
at 339-298-2156 or Email.

About Pharmaceutical Executive:
Pharmaceutical Executive probes the interface of business practice and public
policy for the global biopharmaceutical, vaccine and medical device
industries. PharmExec's editorial remit covers strategy in the "c-suite," as
well as regulatory and legal actions; sales promotion and marketing; R&D;
finance; HR; pricing and market access; and new technology. Published by
Advanstar, PharmExec's editorial content is available in the award-winning
monthly print edition, as well as in a number of digital platforms. For more
information, please visit or contact Bill Looney, Editor in
Chief, at 212-951-6735 or Email.

Read more news from CBI.


Press spacebar to pause and continue. Press esc to stop.